CGRP mAb Iv denied as not medically necessary by Humana?

Humana's specific coverage criteria for cgrp mab iv are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Denied Your IV CGRP Monoclonal Antibody — Medical Necessity

Humana's medical-necessity denial for an intravenous CGRP monoclonal antibody means the plan's reviewer concluded that the submitted documentation did not establish that the treatment was necessary given your specific clinical profile. This is the most common denial type for CGRP mAbs and is also one of the most frequently overturned on appeal, because the clinical record almost always contains the evidence needed — it simply was not presented in the structured format the reviewer required.

## Why This Denial Is Appealable

Humana's medical-necessity standard for preventive migraine therapy is defined in its published coverage policy. That policy will specify the diagnostic criteria (e.g., migraine frequency and type), the prior-treatment history required, and any documentation a prescriber must provide. If your chart contains evidence meeting each criterion — and for most patients with CGRP prescriptions it does — the denial can be reversed by presenting that evidence in a clear, criterion-by-criterion format.

## Federal Appeal Framework

• Internal appeal: File under ACA §2719 / ERISA §503. You are entitled to a full-and-fair review. Submit within the deadline on your denial letter, typically 180 days for non-grandfathered plans.
• Request the clinical criteria: Before or alongside your appeal, request from Humana the specific clinical criteria used to deny the claim. You are entitled to this information under ERISA.
• External review: If the internal appeal is upheld, escalate to independent external review within approximately four months of the final internal denial.
• Expedited review: Available if standard processing would seriously jeopardize your health. Document your current migraine burden in the request.

## Documentation to Gather

1. Diagnosis confirmation — neurologist or treating physician notes documenting your migraine diagnosis, frequency (number of headache days per month from headache diary or chart), and impact on function. 2. Prior preventive treatment history — for each prior preventive agent tried: the drug name, start and stop dates, dosage regimen as documented in the chart, and outcome (inadequate efficacy or intolerance with clinical details). This is the single most important document category. 3. Prescriber medical-necessity letter — a structured letter from the neurologist or prescribing physician that maps your clinical profile to each of Humana's published medical-necessity criteria, citing specific chart dates. 4. Functional-impact documentation — records showing how your migraines affect work, daily activities, or require acute-care use (ER visits, urgent care notes, work-absence records). 5. Humana coverage policy — obtain the current published criteria and use them as the checklist for your appeal package.

## Criteria-Mapping Structure

| Humana Medical-Necessity Criterion | Supporting Chart Evidence | |---|---| | Confirmed migraine diagnosis (type/frequency) | [Neurologist note, date, documented headache days/mo] | | Prior preventive therapies tried and failed | [Drug name, dates, chart-documented outcome — for each] | | Prescribing provider is appropriate specialist | [Provider name, specialty, NPI] | | Functional or clinical severity documented | [Relevant visit notes, ER records, diary, dates] |